Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: Am J Hematol. 2009 Apr;84(4):221–227. doi: 10.1002/ajh.21363

Figure 3.

Figure 3

Decreased NO availability after L-NAME injection increases complement-mediated platelet activation. (A) sP-selectin levels in plasma after L-NAME injection (0.05 mg/g body weight). *P < 0.05 vs. mCd59ab+/+/C3+/+, **P < 0.05 vs. mCd59ab−/−/C3+/+. (B) Plasma level of vWF in mCd59ab−/−/C3+/+ before and after L-NAME injection. All other pair-wise comparisons vs. mCd59ab+/+/C3+/+ were not statistically significant. (C) *P < 0.05 vs. baseline. The plasma NO levels, measured as levels of nitrites and nitrates, were determined at 4 hrs after L-NAME injection (0.05 mg/g body weight) or 4 hr after L-NAME (0.05 mg/g body weight) Plus NOC-18 injection (0.02 mg/g body weight) (15 min before L-NAME injection).